Related references
Note: Only part of the references are listed.Regulatory T-cell phenotypes in children with sickle cell disease
Asmaa M. Zahran et al.
PEDIATRIC RESEARCH (2022)
Research in Sickle Cell Disease: From Bedside to Bench to Bedside
Gabriel Salinas Cisnero et al.
HEMASPHERE (2021)
Effect of Hydroxyurea Treatment on the Inflammatory Markers Among Children With Sickle Cell Disease
Asmaa M. Zahran et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2020)
Immune mechanisms involved in sickle cell disease pathogenesis: current knowledge and perspectives
Julia Teixeira Cottas de Azevedo et al.
IMMUNOLOGY LETTERS (2020)
CD4+ T Cell Profile and Activation Response in Sickle Cell Disease Patients with Osteonecrosis
Paula B. Daltro et al.
MEDIATORS OF INFLAMMATION (2020)
Circulating Microparticles in Children With Sickle Cell Anemia in a Tertiary Center in Upper Egypt
Asmaa M. Zahran et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2019)
Hydroxyurea for Children with Sickle Cell Anemia in Sub-Saharan Africa
Leon Tshilolo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Hydroxyurea prescription, availability and use for children with sickle cell disease in Italy: Results of a National Multicenter survey
Raffaella Colombatti et al.
PEDIATRIC BLOOD & CANCER (2018)
Placenta growth factor augments airway hyperresponsiveness via leukotrienes and IL-13
Marthe-Sandrine Eiymo Mwa Mpollo et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Alteration of lymphocyte phenotype and function in sickle cell anemia: Implications for vaccine responses
Emmanuel Balandya et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Acute hemolytic vascular inflammatory processes are prevented by nitric oxide replacement or a single dose of hydroxyurea
Camila Bononi Almeida et al.
BLOOD (2015)
Immune parameter analysis of children with sickle cell disease on hydroxycarbamide or chronic transfusion therapy
Robert S. Nickel et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Hydroxyurea therapy for sickle cell anemia
Patrick T. McGann et al.
EXPERT OPINION ON DRUG SAFETY (2015)
Hydroxyurea Increases Plasma Concentrations of Microparticles and Reduces Coagulation Activation and Fibrinolysis in Patients with Sickle Cell Anemia
Denise Menezes Brunetta et al.
ACTA HAEMATOLOGICA (2014)
Partial dysfunction of Treg activation in sickle cell disease
Benoit Vingert et al.
AMERICAN JOURNAL OF HEMATOLOGY (2014)
Predictors of splenic function preservation in children with sickle cell anemia treated with hydroxyurea
Kerri A. Nottage et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2014)
Immunologic Effects of Hydroxyurea in Sickle Cell Anemia
Howard M. Lederman et al.
PEDIATRICS (2014)
Hydroxyurea and a cGMP-amplifying agent have immediate benefits on acute vaso-occlusive events in sickle cell disease mice
Camila Bononi Almeida et al.
BLOOD (2012)
Failure to normalize lymphopenia following trauma is associated with increased mortality, independent of the leukocytosis pattern
Daithi S. Heffernan et al.
CRITICAL CARE (2012)
Airway Hyperresponsiveness in Children With Sickle Cell Anemia
Joshua J. Field et al.
CHEST (2011)
Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG)
Winfred C. Wang et al.
LANCET (2011)
The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS)
Ersi Voskaridou et al.
BLOOD (2010)
NKT cells mediate pulmonary inflammation and dysfunction in murine sickle cell disease through production of IFN-γ and CXCR3 chemokines
Kori L. Wallace et al.
BLOOD (2009)
Increased adhesive properties of neutrophils in sickle cell disease may be reversed by pharmacological nitric oxide donation
Andreia A. Canalli et al.
HAEMATOLOGICA (2008)
Leukocyte numbers correlate with plasma levels of granulocyte-macrophage colony-stimulating factor in sickle cell disease
Nicola Conran et al.
ANNALS OF HEMATOLOGY (2007)
Th1 and Th2 cytokine profiles in sickle cell disease
R Raghupathy et al.
ACTA HAEMATOLOGICA (2000)
Share Paper
